Screener
SELLAS Life Sciences Group, Inc. SLS Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -39.6%+141pp | -43.6%+101pp | -66.9%— | -84.3%— | -180.7%+707pp | |
| Return on invested capital | -4,297.6%— | -4,437.7%— | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 18.8×+13.9× | 17.2×+12.6× | 10.7×+9.0× | 8.3×+6.0× | 4.9×+3.9× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×-0.1× | 0×0.0× | 0×-0.2× | |
| Per Share | ||||||
| Book value per share | $0.73+174% | $0.62+96.9% | $0.65+320% | $0.42+80.8% | $0.27+425% | |
| Valuation | ||||||
| Market capitalization | $2.29B+971% | $759.63M+674% | $537.01M+634% | $201.22M+150% | $176.61M+157% | |
| Price / book | 16.6×+11.9× | 7.1×+3.5× | 7.6×-0.2× | 4.4×-0.7× | 6.8×-16.8× |
FAQ
- What are SELLAS Life Sciences Group, Inc.'s profit margins?
- SELLAS Life Sciences Group, Inc. (SLS) runs a 90.0% gross margin and a -4195.0% operating margin, with a -4130.1% net margin.
- Where do SELLAS Life Sciences Group, Inc.'s ratios come from?
- Every ratio is computed from SELLAS Life Sciences Group, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.